# Safety and Immunogenicity of a Monovalent Inactivated Influenza H3N2 Variant (H3N2v) Vaccine in Adult and Elderly Populations

> **NCT01746082** · PHASE2 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 211 (actual)

## Conditions studied

- Influenza

## Interventions

- **BIOLOGICAL:** Influenza A/H3N2 variant Vaccine

## Key facts

- **NCT ID:** NCT01746082
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-01
- **Primary completion:** 2013-08
- **Final completion:** 2013-08
- **Target enrollment:** 211 (ACTUAL)
- **Last updated:** 2014-02-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01746082

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01746082, "Safety and Immunogenicity of a Monovalent Inactivated Influenza H3N2 Variant (H3N2v) Vaccine in Adult and Elderly Populations". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT01746082. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*